why choose us

First received: November 06, 2023

Clinical Trial: Registry for Systemic Eczema Treatments

Study Status: Completed

Recruit Status: RECRUITING

Condition: Atopic Dermatitis

Study Type: OBSERVATIONAL


Official Title: Registry for Systemic Eczema Treatments

Brief Summary: The Registry for Systemic Eczema Therapies (RESET) registry is a database and biospecimen repository for patients with pediatric-onset atopic dermatitis (AD) who have used or will initiate any systemic treatment(s) for AD.The goal of the registry is to enable more efficient research recruitment and data collection as well as timely notification to enrollees about newly FDA-approved treatments for AD.

Read more